Skip to main content
Livermore
Livermore
ZHEN

Kent Lake PR LLC

SEC CIK
0002037231
Latest filing
Nov 14, 2025

The latest 13F from Kent Lake PR LLC covers Q3 2025 (filed Nov 14, 2025): 40 long positions worth $195.5M. The top 10 holdings make up 52.7% of the portfolio, and the largest is Pennant Group, Inc. (PNTG) at 11.2%. Livermore has 5 filings on Form 13F from this institution, going back to Q3 2024.

What changed in Q3 2025

Share counts compared with Q2 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
17
Est. +$68.3M
Added
8
Est. +$17.6M
Reduced
14
Est. −$47.3M
Sold out
16
Est. −$68.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. PNTGPennant Group, Inc.
    11.2%$21.8MHistory
  2. IARTIntegra Lifesciences Holdings Corp
    5.5%$10.8MHistory
  3. NPCENeuroPace Inc
    5.3%$10.3MHistory
  4. VYXNCR Voyix Corp
    4.8%$9.41MHistory
  5. UPWKUpwork, Inc
    4.8%$9.29MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. IARTIntegra Lifesciences Holdings Corp
    +$10.8MNewHistory
  2. PNTGPennant Group, Inc.
    +$10.1MAddedHistory
  3. UPWKUpwork, Inc
    +$9.29MNewHistory
  4. MLABMesa Laboratories Inc
    +$9.01MNewHistory
  5. CDNACareDx, Inc.
    +$8.00MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. IARTIntegra Lifesciences Holdings Corp
    +5.51 pp0.0% → 5.5%History
  2. PNTGPennant Group, Inc.
    +5.04 pp6.1% → 11.2%History
  3. UPWKUpwork, Inc
    +4.75 pp0.0% → 4.8%History
  4. MLABMesa Laboratories Inc
    +4.61 pp0.0% → 4.6%History
  5. CDNACareDx, Inc.
    +4.09 pp0.0% → 4.1%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CNXCConcentrix Corp
    −$14.1MSold outHistory
  2. VYXNCR Voyix Corp
    −$9.41MReducedHistory
  3. QTRXQuanterix Corp
    −$7.06MReducedHistory
  4. MYGNMyriad Genetics Inc
    −$6.64MSold outHistory
  5. GRPNGroupon, Inc.
    −$5.85MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CNXCConcentrix Corp
    −6.23 pp6.2% → 0.0%History
  2. QTRXQuanterix Corp
    −3.97 pp6.7% → 2.8%History
  3. VYXNCR Voyix Corp
    −2.94 pp7.8% → 4.8%History
  4. MYGNMyriad Genetics Inc
    −2.93 pp2.9% → 0.0%History
  5. GRPNGroupon, Inc.
    −2.58 pp2.6% → 0.0%History

Metrics

13F metrics for Q3 2025, computed only from the numbers in the filings. Definitions below.

Portfolio value
$195.5M
−$31.3M (−13.8%) vs. prior quarter
Positions
40
+1 vs. prior quarter
Top 10 concentration
52.7%
Top 10 as share of value
Turnover
40.7%
Q3 2025, one quarter
Average holding period
3.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q3 2024), so positions held before then are understated.

13F filings by quarter

5 quarters, going back to Q3 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $251.8M (Q3 2024)

Q3 2024: $251.8MQ4 2024: $236.4MQ1 2025: $216.6MQ2 2025: $226.8MQ3 2025: $195.5M
Q3 2024Q3 2025
13F filings of Kent Lake PR LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2025Nov 14, 202540$195.5MPNTGIARTNPCEvs. Q2 2025SEC
Q2 2025Aug 14, 202539$226.8MVYXQTRXCNXCvs. Q1 2025SEC
Q1 2025May 15, 202531$216.6MVYXQTRXCNXCvs. Q4 2024SEC
Q4 2024Feb 14, 202540$236.4MNPCEEHABUEICvs. Q3 2024SEC
Q3 2024Nov 14, 202449$251.8MPNTGZIMVXPOF–SEC

13D and 13G filings

Companies where Kent Lake PR LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Kent Lake PR LLC does not currently report owning 5% or more of any company.

Latest filings

20 filings on file made by Kent Lake PR LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Kent Lake PR LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
UEICUniversal Electronics IncNov 18, 202511:01 AM ET13G/A4.90%667.4K shares−1.50 ppfrom 6.40%Below 5%Nov 14, 2025SEC
UEICUniversal Electronics IncOct 24, 202511:48 AM ET13G/A6.40%849.1K shares−1.00 ppfrom 7.40%Oct 22, 2025SEC
UEICUniversal Electronics IncAug 27, 20256:28 PM ET13D/A7.40%990.9K shares−1.20 ppfrom 8.60%Aug 25, 2025SEC
QTRXQuanterix CorpJul 15, 20255:15 PM ET13D/A4.50%2.09M shares−2.40 ppfrom 6.90%Below 5%Jul 11, 2025SEC
UEICUniversal Electronics IncMay 5, 20256:17 PM ET13D/A8.60%1.13M shares+0.40 ppfrom 8.20%May 2, 2025SEC
UEICUniversal Electronics IncMar 27, 20255:06 PM ET13D8.20%1.08M shares+0.40 ppfrom 7.80%Mar 27, 2025SEC
QTRXQuanterix CorpMar 3, 20255:00 PM ET13D/A6.90%2.65M shares+0.99 ppfrom 5.91%Feb 28, 2025SEC
STIMNeuronetics, Inc.Feb 14, 20252:17 PM ET13G/A0.00%0 shares−6.90 ppfrom 6.90%Below 5%Dec 31, 2024SEC
NPCENeuroPace IncFeb 14, 20252:07 PM ET13G/A4.90%1.48M shares−0.10 ppfrom 5.00%Below 5%Dec 31, 2024SEC
HHSHarte Hanks IncFeb 14, 20251:57 PM ET13G/A2.50%180.2K shares−2.50 ppfrom 5.00%Below 5%Dec 31, 2024SEC
CHRNChronoScale Holdings CorpFeb 14, 20251:47 PM ET13G/A4.60%1.00M shares−3.10 ppfrom 7.70%Below 5%Dec 31, 2024SEC
QTRXQuanterix CorpFeb 13, 20251:45 PM ET13D5.91%2.28M sharesNewFeb 7, 2025SEC
VAPOVapotherm IncNov 14, 20242:59 PM ET13G0.00%0 sharesNewBelow 5%Sep 30, 2024SEC
SILCSilicom Ltd.Nov 14, 20242:53 PM ET13G0.00%0 sharesNewBelow 5%Sep 30, 2024SEC
MDRXVeradigm Inc.Nov 14, 20242:47 PM ET13G4.80%5.13M sharesNewBelow 5%Sep 30, 2024SEC
UEICUniversal Electronics IncNov 14, 20242:39 PM ET13G7.80%1.01M sharesNewSep 30, 2024SEC
STIMNeuronetics, Inc.Nov 14, 20242:32 PM ET13G6.90%2.08M sharesNewSep 30, 2024SEC
NPCENeuroPace IncNov 4, 20244:51 PM ET13G5.00%1.47M sharesNewOct 25, 2024SEC
HHSHarte Hanks IncSep 13, 20243:08 PM ET13G5.00%365.0K sharesNewSep 3, 2024SEC
CHRNChronoScale Holdings CorpSep 12, 20244:29 PM ET13G7.70%1.67M sharesNewAug 30, 2024SEC